Europium Fluorescence to Visualize N-Butyl 2-Cyanoacrylate in Embolized Vessels of an Arteriovenous Malformation Swine Model

References

1. ↵
   Wikholm G, Lundqvist C, Svendsen P. Embolization of cerebral arteriovenous malformations: part I–technique, morphology, and complications. Neurosurgery 1996;39:448-459

   CrossRefPubMedWeb of Science
2. Wikholm G. Occlusion of cerebral arteriovenous malformations with N-butyl cyano-acrylate is permanent. AJNR Am J Neuroradiol 1995;16:479-482

   Abstract
3. Barr JD, Hoffman EJ, Davis BR, Edgar KA, Jacobs CR. Microcatheter adhesion of cyanoacrylates: comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylate. J Vasc Interv Radiol 1999;10:165-168

   PubMedWeb of Science
4. ↵
   Lieber BB, Wakhloo AK, Wodenscheck JA, et al. Kinetics of embolization in a chronic model of arteriovenous malformation model. ASME/AIChE/ASCE/BMES Summer Bioengineering Conference, June 16–20, 1999, Big Sky MT
5. Wakhloo AK, Lieber BB, Divani AA, et al. The effect of glacial acetic acid on the kinetics of n-butyl 2-cyanoacrylate embolization in a chronic and acute swine arteriovenous malformation model. ASPNR/ASTIN/ASSR Joint Meeting, May 22–28, 1999, San Diego CA
6. ↵
   Siekmann R, Wakhloo AK, Lieber BB, Gounis MJ, Divani AA, Hopkins LN. Endovascular and combined surgical-endovascular creation of an arteriovenous malformation (AVM) model in swine: technical description and hemodynamics. AJNR Am J Neuroradiol 2000;21:1722-1725

   Abstract/FREE Full Text
7. ↵
   Massoud TF, Ji C, Vinuela F, et al. Laboratory simulations and training in endovascular embolotherapy with a swine arteriovenous malformation model. AJNR Am J Neuroradiol 1996;17:271-279

   Abstract
8. Massoud TF, Ji C, Vinuela F, Guglielmi G, Duckwiler GR, Gobin YP. An experimental arteriovenous malformation model in swine: anatomical basis and construction technique. AJNR Am J Neuroradiol 1994;15:1537-1545

   Abstract/FREE Full Text
9. Murayama Y, Massoud TF, Vinuela F. Hemodynamic changes in arterial feeders and draining veins during embolotherapy of arteriovenous malformations: an experimental study in a swine model. Neurosurgery 1998;43:96-106

   CrossRefPubMedWeb of Science
10. ↵
    Pani KC, Gladieux G, Brandes G, Kulkarni RK, Leonard F. The degradation of n-butyl alpha-cyanoacrylate tissue adhesive II. Surgery 1968;63:481-489

    PubMed
11. Galil KA, Schofield ID, Wright GZ. Detection of cyanoacrylate tissue adhesives in histological sections. J Biomed Mater Res 1984;18:609-616

    PubMedWeb of Science
12. Lundie MJ, Ellyatt D, Kaufmann JCE, Vinters HV. Staining procedure to aid in assessment of bucrylate histotoxicity in tissue sections. Arch Pathol Lab Med 1985;109:779-781

    PubMedWeb of Science
13. ↵
    de Haas RR, Verwoerd NP, van der Corput MP, van Gijlswijk RP, Siitari H, Tanke HJ. The use of peroxidase-mediated deposition of biotin-tyramide in combination with time-resolved fluorescence imaging of europium chelate label in immunohistochemistry and in situ hybridizaton. J Histochem Cytochem 1996;44:1091-1099

    Abstract/FREE Full Text
14. Laukkanen ML, Orellana A, Keinanen K. Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes. Application in fluoroimmunoassay. J Immunol Meth 1995;185:95-102

    PubMed
15. ↵
    Yuan J, Matsumoto K. Synthesis of a new tetradentate beta-diketonate-europium chelate and its application for time-resolved fluorimetry of albumin. J Pharm Biomed Anal 1997;15:1397-1403

    CrossRefPubMedWeb of Science
16. Ci YX, Yang XD, Chang WB. Fluorescence labelling with europium chelate of beta-diketones and application in time-resolved fluoroimmunoassays (TR-FIA). J Immunol Meth 1995;179:233-241

    PubMed
17. ↵
    Bjartell A, Laine S, Pettersson K, Nilsson E, Lovgren T, Lilja H. Time-resolved fluorescence in immunocytochemical detection of prostate-specific antigen in prostatic tissue sections. Histochem J 1999;31:45-52

    CrossRefPubMedWeb of Science
18. ↵
    Kimura H, Yuan J, Wang G, Matsumoto K, Mukaida M. Highly sensitive quantitation of methamphetamine by time-resolved fluoroimmunoassay using a new europium chelate as a label. J Anal Toxicol 1999;23:11-16

    Abstract/FREE Full Text
19. Heyduk E, Heyduk T. Thiol-reactive, luminescent Europium chelates: luminescence probes for resonance energy transfer distance measurements in biomolecules. Anal Biochem 1997;248:216-227

    CrossRefPubMedWeb of Science
20. Takalo H, Mukkala VM, Mikola H, Liitti P, Hemmila I. Synthesis of europium(III) chelates suitable for labeling of bioactive molecules. Bioconjugate Chem 1994;5:278-282

    CrossRefPubMedWeb of Science
21. Tompkins SM, Rota PA, Moore JC, Jensen PE. A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins. J Immunol Meth 1993;163:209-216

    CrossRefPubMedWeb of Science
22. ↵
    Wilkinson DA, Watkin JE. Europium aryl-β-diketone complexes as fluorescent dyes for the detection of cyanoacrylate developed fingerprints on human skin. Forensic Sci Int 1993;60:67-79

    PubMed
23. ↵
    Wakhloo AK, Lieber BB, Rudin S, Duffy-Fronckowiak MD, Mericle RA, Hopkins LN. A novel approach to flow quantification in brain arteriovenous malformations prior to enbucrilate embolization: use of insoluble contrast (Ethiodol droplet) angiography. J Neurosurg 1998;89:395-404

    CrossRefPubMed
24. ↵
    Marriott G, Heidecker M, Diamandis EP, Yan-Marriott Y. Time-resolved delayed luminescence image microscopy using a europium ion chelate complex. Biophys J 1994;67:957-965

    PubMedWeb of Science
25. ↵
    Seveus L, Vaisala M, Hemmila I, Kojola H, Roomans GM, Soini E. Use of fluorescent europium chelates as labels in microscopy allows glutaraldehyde fixation and permanent mounting and leads to reduced autofluorescence and good long-term stability. Microscopy Res Tech 1994;28:149-154
26. ↵
    Stoesslein F, Ditscherlein G, Romaniuk PA. Experimental studies on new liquid embolization mixtures (Histoacryl-Lipiodol, Histoacryl-Panthopaque). Cardiovasc Intervent Radiol 1982;5:264-267

    CrossRefPubMedWeb of Science
27. ↵
    Debrun GM, Aletich V, Ausmam JI, Charbel F, Dujovny M. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112-121

    CrossRefPubMedWeb of Science
28. Pile-Spellman J, Young WL, Joshi S, et al. Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations, technical case report. Neurosurgery 1999;44:881-886

    CrossRefPubMedWeb of Science
29. ↵
    Kish KK, Rapp SM, Wilner HI, Wolfe D, Thomas LM, Barr J. Histopathologic effects of transarterial bucrylate occlusion of intracerebral arteries in mongrel dogs. AJNR Am J Neuroradiol 1983;4:385-387

    Abstract/FREE Full Text
30. ↵
    Fournier D, Terbrugge K, Rodesch G, Lasjaunias P. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology 1990;32:497-501

    CrossRefPubMed
31. Calvo WJ, Lieber BB. Histologic visualization embolization. Provisional Patent Application 60/231, 816, September 2000